Discovery Knows No Bounds

Discovery knows no bounds

Copyright 2016 RMM.

Phase I study of delivery of autologous bone marrow derived mononuclear cells to myopathic right ventricle in patients with Ebstein anomaly during surgical intervention

Research Grant Recipient: Kimberly Holst, MD

Grant Period: 2016-2018

Award Value: $500,000

Site: Mayo Clinic

Click here to read Holst's First Year Progress Report

The goal of this Phase I study is to establish the safety and feasibility of intramyocardial injection of autologous bone marrow derived mononuclear cells (BM-MNC) into the myopathic right ventricle of patients with Ebstein anomaly (EA) at time of elective cardiac surgery.

Dr. Holst is a general and thoracic surgery resident at Mayo Clinic and a resident in the Clinician Investigator Training Program.

Explore